Status:
COMPLETED
Surgical Correction of Moderate Ischemic Mitral Regurgitation
Lead Sponsor:
Shaare Zedek Medical Center
Conditions:
Moderate Ischemic Mitral Regurgitation
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to try and determine whether repair of moderate ischemic mitral regurgitation at the time of coronary bypass graft surgery (CABG) has an impact on survival.We will compare...
Eligibility Criteria
Inclusion
- patients undergoing coronary bypass surgery who have moderate degree of ischemic MR
Exclusion
- etiology of mitral regurgitation other than ischemic, degree of regurgitation other than moderate.
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00394797
Last Update
June 1 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shaare Zedek Medical Center
Jerusalem, Israel, 91031